Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

1 year ago

Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash. 

More Stories

Turkiye arrests nine amid anger over deadly hotel fire

6 mins ago

‘Skull without a jaw’: Gaza survivors search for what remains of the dead

6 mins ago

CNBC Daily Open: Trump’s tariff delay spurs markets

6 mins ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

Tinubu pledges justice in Ogoniland as negotiation to restart oil production begins

5 mins ago

‘Resetting America’: Understanding Trump’s policy directions in his second term

5 mins ago

ANALYSIS: Seven key issues that shaped Nigeria’s agriculture sector in 2024

5 mins ago

Saudi Arabia sponsors 20 Nigerians for lesser Hajj

5 mins ago

US scraps ban on immigration raids in churches, hospitals, schools

5 mins ago